# SPIRONOLACTONE
> **ANDA205936** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2018-07-18
## Drug
- **FDA Application Number:** ANDA205936
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE
- **Generic name:** SPIRONOLACTONE
- **Active ingredients:** SPIRONOLACTONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2018-07-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205936)
---
*MORVS · CC0 1.0*